Global Cold Pain Therapy Market is Estimated to Reach $1.4 Billion by 2025, Says Accurize Market Research


Global Cold Pain Therapy Market is Estimated to Reach $1.4 Billion by 2025, Says Accurize Market Research

Global Cold Pain Therapy Market report published by Accurize Market Research forecast that the global market is expected to reach $1.4 billion by 2025; growing at a CAGR of 4.6% from 2017 to 2025. By geography, Asia Pacific and Europe are expected to grow at a CAGR of 6.3% and 4.4%, respectively, during the forecast period.

To browse the complete report, visit at

Increased healthcare awareness to drive the global cold pain therapy market

Crucial factors propelling the growth of global cold pain therapy market includes rising importance of physical activities such as exercise and gym, frequent injuries during sports activities, and growing awareness among end user’s due to several promotions. But the risk of side-effects, and limited clinical evidences supporting the cold pain therapy would limit the adoption among consumers. Moreover, rising healthcare spending and stringent regulatory approval for oral pain medicines would create growth opportunities for the market.

Market Segmentation

The global cold pain market segmented on the basis of product type, application. The product type segment includes OTC based products and prescription based products. The application segment of the global cold pain market includes musculoskeletal disorder, sport medicine, post-operative, post-trauma, and physical therapy. Based on geography, the cold pain therapy market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

"OTC based products accounted for the largest market share in the product type segment", says Accurize

In the product type segment, OTC based products accounted the largest market share in 2017. Also, musculoskeletal dominated the application segment with maximum market share.

"North America dominated the global market with the highest market share over the forecast period", says Accurize

North America and Europe dominated the market with largest market share in 2017, with 36% and 29%, respectively. Asia-Pacific will attain the fastest CAGR during the forecast period in terms of growth, driven by increased investments, owing to presence of large patient base, rising use of generic drugs, and improving healthcare services.

Top players in the market

Major companies operating in the market include Hisamitsu Pharmaceutical Co., Inc., 3M Company, Breg Inc., Johnson & Johnson, Ossurhf, ROHTO Pharmaceutical Co., Ltd., Sanofi, DJO Finance LLC, Beiersdorf AG, and Medline Industries Inc., among others.


Contact Us

Stephen Jones,

Head - Sales

Accurize Market Research



Tel: +91-612-2369997